Silk Road Medical Announces Investor Education Webcast with Key Opinion Leaders

Rhea-AI Summary

Silk Road Medical, Inc. will host an investor education webcast on May 25, 2023, to educate investors on TCAR and the treatment of carotid artery disease. The event will include a discussion between Dr. Sumaira Macdonald and key opinion leaders in the field.

Positive

• None.

Negative

• No concrete business takes were identified in the given PR.

SUNNYVALE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that the company will host an investor education webcast at 11:00 a.m. Eastern Time on Thursday, May 25, 2023. The event represents the first in a series of webcasts being organized by the company to educate investors on TCAR and the treatment of carotid artery disease.

The event will include a discussion between Silk Road Medical’s Executive Medical Director, Dr. Sumaira Macdonald, and key opinion leaders in the treatment of carotid artery disease. The event will conclude with an interactive question and answer session. A live and replay version of the webcast will be available at https://investors.silkroadmed.com.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com

Media:
Michael Fanucchi
Silk Road Medical
mfanucchi@silkroadmed.com

FAQ

When is Silk Road Medical hosting an investor education webcast?

Silk Road Medical is hosting the webcast on May 25, 2023.

What is the purpose of the webcast?

The webcast aims to educate investors on TCAR and the treatment of carotid artery disease.

Who will be participating in the discussion during the webcast?

Dr. Sumaira Macdonald and key opinion leaders in the treatment of carotid artery disease will be participating in the discussion.

Where can I access the live and replay version of the webcast?

The live and replay version of the webcast will be available at https://investors.silkroadmed.com.